There should always be hope. No one should ever lose a child or a loved one because of lack of funds.
Every day in the United States, nearly a dozen children are diagnosed with brain and other central nervous system (CNS) tumors. These comprise the third most common type of childhood cancer, behind leukemia and lymphoma, and the deadliest form. Of the approximately 4,200 children diagnosed with these lethal tumors (of which approximately 2,000 are brain cancers) each year, fewer than 20 percent will survive. This is despite decades of research conducted at medical centers across the United States.
Even those who do survive often face recurrence as well as serious long-term effects that can include cognitive deficits, neuropathy, hearing loss and other conditions stemming from both their disease and the impact of treatment on developing brains. Thus for many, survivorship can mean physical impairment, learning challenges and emotional trials. Clearly, there is a need for developing more effective, less toxic therapies that will increase the survival of children with brain cancer while also assuring them a higher quality of life.